News Focus
News Focus
Followers 200
Posts 25579
Boards Moderated 0
Alias Born 04/03/2010

Re: dennisdave post# 521818

Friday, 10/14/2022 10:54:49 AM

Friday, October 14, 2022 10:54:49 AM

Post# of 818653
The new paradigm is much abbreviated post approval. These guys are, I am pretty sure, trying to not just demonstrate efficacy for gbm, but with biomarkers, for tumors generally.

We’ll see, but with Real World Data and data summaries, as a means for extension to other indications, I actually expect that immunotherapies will be much more quickly and broadly available than some expect.

And it is already happening in some quarters. This is not a prediction of the future, this is what the law already says.

https://investorshub.advfn.com/boards/read_msg.aspx?message_id=169981653

I own NWBO. My posts on iHub are always posted expressly as just my humble opinion (IMHO) and none are advice, just my opinion. I am NOT a financial advisor, and it is assumed that everyone is responsible for their own due diligence.

Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent NWBO News